- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Elan in talks to sell stake to Bristol
1 June 2009
Irish biotech firm is reportedly discussing selling a minority-stake to Bristol-Myers Squibb.
According to a report in Reuters, an unamed source believes that an agreement could come as early as this week. Elan is also in talks with a second party, but the stauts of these discussions are as yet unknown.
In January, Elan hired Citigroup to conduct a strategic review of its business, which it said could lead to a sale or merger of the company.
Elan and Bristol-Myers Squibb declined to comment.
www.elan.com
www.bms.com
IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment
August 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.
